{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:36:23Z","timestamp":1771493783308,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T00:00:00Z","timestamp":1606608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The occurrence of calcinosis cutis as a clinical feature of dermatomyositis in adult patients is not well understood. Cohort studies of adult patients with calcinosis are rare. We systematically describe the clinical features, treatments and outcomes of adult patients with calcinosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We initially enrolled 627 adult DM patients. Of those enrolled, 35 (5.6%) were found to have calcinosis. We analysed the clinical features associated with calcinosis in this subgroup. The risk factors associated with calcinosis were analysed using the Poisson regression model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Multivariate analysis showed that a younger age at disease onset [odds ratio (OR)\u2009=\u20090.945, 95% CI 0.925, 0.966, P\u2009&amp;lt;\u20090.001], dysphagia (OR\u2009=\u20092.609, 95% CI 1.189, 5.728, P\u2009=\u20090.017), skin ulcer (OR\u2009=\u20095.705, 95% CI 3.041, 10.705, P\u2009&amp;lt;\u20090.001) and the presence of anti-nuclear matrix protein 2 antibody (OR\u2009=\u20095.917, 95% CI 2.754, 12.714, P\u2009&amp;lt;\u20090.001) were independently associated with calcinosis. In both the low- and high-dose prednisone treatment groups, no difference in treatment response was seen between the bisphosphonate treatment group and the group not receiving bisphosphonate treatment (P\u2009=\u20091.000 and P\u2009=\u20090.375, respectively). A follow-up study revealed that the mortality rate of the calcinosis group was 5.7%. Additionally, 60.6% of the cases had a chronic polycyclic disease course and 17.1% had mild complications secondary to calcinosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Calcinosis is an uncommon, but significant clinical feature in adult patients with DM. Bisphosphonates were not found to effectively treat calcinosis, however, the overall health outcomes of adult DM patients with calcinosis were favourable.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa618","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T11:34:03Z","timestamp":1598787243000},"page":"2958-2962","source":"Crossref","is-referenced-by-count":14,"title":["Clinical features, treatments and outcomes of calcinosis in adult patients with dermatomyositis: a single cohort study"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9361-3444","authenticated-orcid":false,"given":"Wei","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Beijing Key Lab for Immune-Mediated Inflammatory Diseases, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanbo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Beijing Key Lab for Immune-Mediated Inflammatory Diseases, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sizhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Beijing Key Lab for Immune-Mediated Inflammatory Diseases, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Beijing Key Lab for Immune-Mediated Inflammatory Diseases, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Beijing Key Lab for Immune-Mediated Inflammatory Diseases, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,29]]},"reference":[{"key":"2021061821292750500_keaa618-B1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BOR.0b013e32834ff5cd","article-title":"Soft tissue and subcutaneous calcification in connective tissue diseases","volume":"24","author":"Chander","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2021061821292750500_keaa618-B2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021061821292750500_keaa618-B3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"2021061821292750500_keaa618-B4","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","article-title":"Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset","volume":"53","author":"Tansley","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821292750500_keaa618-B5","first-page":"303","article-title":"Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options","volume":"35","author":"Fredi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821292750500_keaa618-B6","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s10067-018-4216-x","article-title":"Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay","volume":"37","author":"Wang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2021061821292750500_keaa618-B7","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021061821292750500_keaa618-B8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1684\/ejd.2020.3750","article-title":"Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis","volume":"30","author":"Liang","year":"2020","journal-title":"Eur J Dermatol"},{"key":"2021061821292750500_keaa618-B9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","article-title":"Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996","volume":"148","author":"Balin","year":"2012","journal-title":"Arch Dermatol"},{"key":"2021061821292750500_keaa618-B10","doi-asserted-by":"crossref","first-page":"467.","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"2021061821292750500_keaa618-B11","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/rheumatology\/kew313","article-title":"Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study","volume":"55","author":"Baron","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821292750500_keaa618-B12","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1242\/jcs.063586","article-title":"Two-step colocalization of MORC3 with PML nuclear bodies","volume":"123","author":"Mimura","year":"2010","journal-title":"J Cell Sci"},{"key":"2021061821292750500_keaa618-B13","doi-asserted-by":"crossref","first-page":"25964.","DOI":"10.1038\/srep25964","article-title":"Morc3 mutant mice exhibit reduced cortical area and thickness, accompanied by altered haematopoietic stem cells niche and bone cell differentiation","volume":"6","author":"Jadhav","year":"2016","journal-title":"Sci Rep"},{"key":"2021061821292750500_keaa618-B14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.24391","article-title":"Juvenile dermatomyositis calcifications selectively displayed markers of bone formation","volume":"61","author":"Urganus","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021061821292750500_keaa618-B15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","article-title":"Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis","volume":"150","author":"Valenzuela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2021061821292750500_keaa618-B16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12969-017-0199-4","article-title":"Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the Childhood Arthritis and Rheumatology Research Alliance (CARRA)","volume":"15","author":"Orandi","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"2021061821292750500_keaa618-B17","first-page":"135","article-title":"Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis","volume":"28","author":"Marco Puche","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821292750500_keaa618-B18","first-page":"1837","article-title":"Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy","volume":"32","author":"Ambler","year":"2005","journal-title":"J Rheumatol"},{"key":"2021061821292750500_keaa618-B19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/14397595.2014.988197","article-title":"Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis","volume":"25","author":"Tayfur","year":"2015","journal-title":"Mod Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2958\/38695009\/keaa618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2958\/38695009\/keaa618.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T21:30:34Z","timestamp":1624051834000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/2958\/6010469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,29]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,29]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa618","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,11,29]]}}}